Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2418 | 2182 | 46.1 | 89% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
88 | 25697 | ULCERATIVE COLITIS//CROHNS DISEASE//INFLAMMATORY BOWEL DISEASE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | NOD2 | Author keyword | 167 | 57% | 9% | 197 |
2 | CARD15 | Author keyword | 75 | 65% | 3% | 71 |
3 | NOD1 | Author keyword | 64 | 68% | 3% | 56 |
4 | NOD2 CARD15 | Author keyword | 46 | 64% | 2% | 45 |
5 | ATG16L1 | Author keyword | 28 | 52% | 2% | 38 |
6 | NOD2 CARD15 GENE | Author keyword | 23 | 86% | 1% | 12 |
7 | IBD5 | Author keyword | 22 | 81% | 1% | 13 |
8 | DLG5 | Author keyword | 19 | 68% | 1% | 17 |
9 | GIBSON S | Address | 19 | 60% | 1% | 21 |
10 | HARVEY M LYN P MEYERHOFF INFLAMMATORY BOWEL DIS | Address | 18 | 53% | 1% | 24 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NOD2 | 167 | 57% | 9% | 197 | Search NOD2 | Search NOD2 |
2 | CARD15 | 75 | 65% | 3% | 71 | Search CARD15 | Search CARD15 |
3 | NOD1 | 64 | 68% | 3% | 56 | Search NOD1 | Search NOD1 |
4 | NOD2 CARD15 | 46 | 64% | 2% | 45 | Search NOD2+CARD15 | Search NOD2+CARD15 |
5 | ATG16L1 | 28 | 52% | 2% | 38 | Search ATG16L1 | Search ATG16L1 |
6 | NOD2 CARD15 GENE | 23 | 86% | 1% | 12 | Search NOD2+CARD15+GENE | Search NOD2+CARD15+GENE |
7 | IBD5 | 22 | 81% | 1% | 13 | Search IBD5 | Search IBD5 |
8 | DLG5 | 19 | 68% | 1% | 17 | Search DLG5 | Search DLG5 |
9 | RIP2 | 15 | 62% | 1% | 16 | Search RIP2 | Search RIP2 |
10 | CARD15 NOD2 | 15 | 71% | 1% | 12 | Search CARD15+NOD2 | Search CARD15+NOD2 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NOD2 GENE | 149 | 68% | 6% | 131 |
2 | NOD2 | 129 | 44% | 10% | 221 |
3 | CATION TRANSPORTER GENES | 90 | 82% | 2% | 53 |
4 | SUPPORTS LINKAGE | 77 | 89% | 2% | 34 |
5 | LARGE EUROPEAN COHORT | 76 | 78% | 2% | 50 |
6 | HOST RECOGNITION | 69 | 46% | 5% | 112 |
7 | CARD15 MUTATIONS | 56 | 52% | 3% | 76 |
8 | NOD2 VARIANTS | 55 | 69% | 2% | 47 |
9 | NOD2 CARD15 GENE | 55 | 65% | 2% | 53 |
10 | CARD15 | 46 | 70% | 2% | 39 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
NOD proteins: regulators of inflammation in health and disease | 2014 | 66 | 155 | 70% |
Unravelling the pathogenesis of inflammatory bowel disease | 2007 | 1412 | 93 | 32% |
The genetics of Crohn's disease and ulcerative colitis - status quo and beyond | 2015 | 2 | 77 | 56% |
Down the line from genome-wide association studies in inflammatory bowel disease: the resulting clinical benefits and the outlook for the future | 2015 | 3 | 91 | 37% |
Signalling pathways and molecular interactions of NOD1 and NOD2 | 2006 | 413 | 90 | 59% |
Nod-like proteins in immunity, inflammation and disease | 2006 | 409 | 77 | 56% |
Innate and adaptive immunity in inflammatory bowel disease | 2014 | 42 | 104 | 25% |
Genetics and pathogenesis of inflammatory bowel disease | 2011 | 436 | 96 | 21% |
MECHANISMS OF DISEASE Inflammatory Bowel Disease | 2009 | 622 | 107 | 21% |
Advances in IBD genetics | 2014 | 18 | 181 | 47% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GIBSON S | 19 | 60% | 1.0% | 21 |
2 | HARVEY M LYN P MEYERHOFF INFLAMMATORY BOWEL DIS | 18 | 53% | 1.1% | 24 |
3 | INFLAMMATORY BOWEL DIS GRP | 15 | 62% | 0.7% | 16 |
4 | MED SCIGASTROINTESTINAL UNIT | 11 | 100% | 0.3% | 6 |
5 | MEYERHOFF INFLAMMATORY BOWEL DIS | 11 | 69% | 0.4% | 9 |
6 | REGISTRE EPIMAD | 6 | 58% | 0.3% | 7 |
7 | MARTIN BOYER GENET S | 6 | 100% | 0.2% | 4 |
8 | UNIT GASTROENTEROL SOD2 | 5 | 63% | 0.2% | 5 |
9 | PREVENT DENT PERIODONTOL | 4 | 28% | 0.6% | 13 |
10 | CORE UNIT MICROARRAY ANAL | 4 | 75% | 0.1% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000199146 | ANTI SACCHAROMYCES CEREVISIAE ANTIBODIES//ASCA//ANTI SACCHAROMYCES CEREVISIAE ANTIBODY |
2 | 0.0000198890 | BLAU SYNDROME//EARLY ONSET SARCOIDOSIS//CHILDHOOD SARCOIDOSIS |
3 | 0.0000181993 | EPIDEMIOLOGY OF INFLAMMATORY BOWEL DISEASE//MONTREAL CLASSIFICATION//INDETERMINATE COLITIS |
4 | 0.0000118965 | DEXTRAN SULFATE SODIUM//EXPERIMENTAL COLITIS//BIOL CHEM BIOACT |
5 | 0.0000109528 | ADHERENT INVASIVE E COLI//ADHERENT INVASIVE ESCHERICHIA COLI//JE2526 |
6 | 0.0000101035 | INFLAMMASOME//NLRP3//CASPASE 1 |
7 | 0.0000065388 | INFLIXIMAB//VEDOLIZUMAB//ADALIMUMAB |
8 | 0.0000062570 | NFKB1//NFKBIA//NFKB1 GENE |
9 | 0.0000060399 | CD14//CD14 POLYMORPHISM//TLR4 POLYMORPHISM |
10 | 0.0000058915 | DCR3//DECOY RECEPTOR 3//TL1A |